The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edwards Lifesciences Corp shares valued at $87,332 were sold by Lippis Daniel J. on Jan 09 ’26. At $85.70 per share, Lippis Daniel J. sold 1,019 shares. The insider’s holdings dropped to 22,002 shares worth approximately $1.86 million following the completion of this transaction.
Also, BOBO DONALD E JR sold 11,340 shares, netting a total of over 971,429 in proceeds. Following the sale of shares at $85.66 each, the insider now holds 31,870 shares.
Before that, BOBO DONALD E JR had added 45,360 shares to its account. In a trade valued at $3,885,715, the Officer bought Edwards Lifesciences Corp shares for $85.66 each.
As published in a research note from TD Cowen on January 09, 2026, Edwards Lifesciences Corp [EW] has been rated up from a Hold to a Buy and the price target has been revised to $97. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid December. As of November 03, 2025, Raymond James has increased its “Mkt perform” rating to a “an Outperform” for EW. Earlier on October 29, 2025, Wolfe Research upgraded its rating. Their new recommendation was “a Peer perform” for EW stock which previously was a “an Underperform”.
Analyzing EW Stock Performance
On last trading session, Edwards Lifesciences Corp [NYSE: EW] rose 1.67% to $84.49. The stock’s lowest price that day was $82.383, but it reached a high of $84.51 in the same session. During the last five days, there has been a drop of approximately -0.11%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 18.93%.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
RSI (Relative Strength Index) is 49.22 on the 14-day chart, showing neutral technical sentiment.
Is Edwards Lifesciences Corp subject to short interest?
Stocks of Edwards Lifesciences Corp saw a sharp rise in short interest on 2025-12-31 jumping by 0.16 million shares to 7.14 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 6.98 million shares. A jump of 2.22% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.46 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.46.
Which companies own the most shares of Edwards Lifesciences Corp (EW)?
In terms of Edwards Lifesciences Corp share price expectations, FactSet research, analysts set an average price target of 96 in the next 12 months, up nearly 15.52% from the previous closing price of $83.1. Analysts anticipate Edwards Lifesciences Corp stock to reach 108 by 2026, with the lowest price target being 87. In spite of this, 17 analysts ranked Edwards Lifesciences Corp stock as Buy at the end of 2026. On October 29, 2025, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $98.
